Dopamine receptors: From structure to function

被引:2689
作者
Missale, C [1 ]
Nash, SR
Robinson, SW
Jaber, M
Caron, MG
机构
[1] Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst Labs, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Howard Hughes Med Inst Labs, Durham, NC 27710 USA
关键词
D O I
10.1152/physrev.1998.78.1.189
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The diverse physiological actions of dopamine are mediated by at least live distinct G protein-coupled receptor subtypes. Two D-1-like receptor subtypes (D-1 and D-5) couple to the G protein G(s) and activate adenylyl cyclase. The other receptor subtypes belong to the D-2-like subfamily (D-2, D-3, and D-4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels. The genes for the D-1 and D-5 receptors a-e intronless, but pseudogenes of the D-5 exist. The D-2 and D-3 receptors vary in Certain tissues and species as a result of alternative splicing, and the human D-4 receptor gene exhibits extensive polymorphic variation. Ln the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion. Ln the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion. Numerous genetic linkage analysis studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiology of various central nervous system disorders. However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiological functions.
引用
收藏
页码:189 / 225
页数:37
相关论文
共 481 条
[61]  
CASPER D, 1994, J NEUROCHEM, V62, P2166
[62]  
CASPER D, 1995, J NEUROCHEM, V65, P1016
[63]   POTASSIUM CHANNEL BLOCKERS INHIBIT D2 DOPAMINE, BUT NOT A1 ADENOSINE, RECEPTOR-MEDIATED INHIBITION OF STRIATAL DOPAMINE RELEASE [J].
CASS, WA ;
ZAHNISER, NR .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) :147-152
[64]  
CASTELLANO MA, 1993, MOL PHARMACOL, V44, P649
[65]   POTASSIUM CHANNELS INVOLVED IN THE TRANSDUCTION MECHANISM OF DOPAMINE-D2 RECEPTORS IN RAT LACTOTROPHS [J].
CASTELLETTI, L ;
MEMO, M ;
MISSALE, C ;
SPANO, PF ;
VALERIO, A .
JOURNAL OF PHYSIOLOGY-LONDON, 1989, 410 :251-265
[66]   DIFFERENCES IN THE LIGAND-BINDING PROPERTIES OF THE SHORT AND LONG VERSIONS OF THE D2 DOPAMINE RECEPTOR [J].
CASTRO, SW ;
STRANGE, PG .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (01) :372-375
[67]  
CENI MA, 1992, EUR J NEUROSCI, V4, P376
[68]   DEFECTIVE G-PROTEIN ACTIVATION OF THE CAMP PATHWAY IN RAT-KIDNEY DURING GENETIC-HYPERTENSION [J].
CHATZIANTONIOU, C ;
RUAN, XP ;
ARENDSHORST, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2924-2928
[69]   INHIBITION OF NA+,K+-ATPASE IN RAT RENAL PROXIMAL TUBULES BY DOPAMINE INVOLVED DA-1 RECEPTOR ACTIVATION [J].
CHEN, CJ ;
LOKHANDWALA, MF .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (03) :289-295
[70]   DOPAMINE FAILS TO INHIBIT RENAL TUBULAR SODIUM-PUMP IN HYPERTENSIVE RATS [J].
CHEN, CJ ;
BEACH, RE ;
LOKHANDWALA, MF .
HYPERTENSION, 1993, 21 (03) :364-372